Methyl 5-chloropyrazolo[1,5-a]pyridine-3-carboxylate, 96.0%, 250mg

5-METHYL-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXYLIC ACID, 95.0%, 50mg

TAZEMETOSTAT, 98%, 25mg

1,2,3,9-Tetrahydro-9-methyl-4H-carbazole-4-one, 95.0%, 10g

Benzonitrile, 4-[2-(2-cyclopentylidenehydrazinyl)-4-thiazolyl]-, hydrobromide (1:1), 100mg

(2S)-3-[tert-Butoxycarbonyl(isopropyl)amino]-2-(4-chlorophenyl)propanoic acid, 95%, 1g

2-Bromo-1-o-tolyl-propan-1-one, 95.0%, 1g

Methyl 2-amino-3,4-difluorobenzoate, 99.0%, 250mg

Salicylic acid, min. 99%, for biochemistry, 500 g, plastic packaging.

1,4-Naphthalenebis(trifluoromethanesulfonate)>97.0%(GC)5g

6-Chlorobenzo[d]thiazole-2-thiol, 95.0%, 25g

2,4,6-Trimethoxybenzaldehyde, 95.0%, 100g

2-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95%, 1g